| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Michael Reese Hospital, University of Illinois Chicago, Illinois 60616
Correspondence: Address requests for reprints to: Dr. James Magner, Michael Reese Hospital, 2816 South Ellis 216 RC, Chicago, Illinois 60616.
Abstract
Introduction: THYROID-stimulating hormone is a 28,000 dalton, pituitary-derived glycoprotein that is composed of two noncovalently linked subunits,
and β. TSH is chemically related to the pituitary gonadotropins, LH, and FSH, and to placental CG. TSH is synthesized by thyrotropes of the anterior pituitary and stored in secretory granules; it is released into the circulation in a regulated manner, binds to thyroid cells, and activates them to release thyroid hormones.
Smith (1) and Allen (2) performed experiments in the early 20th century suggesting that the pituitary contained a thyrotropic substance. Subsequently the subunit structure of the glycoprotein hormones has been determined, and the amino acid sequences of TSH subunits from several species have been learned. In recent years great progress has been made in determining the structures of TSH
and β-subunit genes and the chromosomal localizations and regulation of those genes. These advances have recently been reviewed by Shupnik et al. (3). The posttranslational processing events of TSH subunits have been learned in some detail, and the kinetics of the oligosaccharide processing and subcellular sites of subunit combination and processing have been studied. Investigations of the secretion, metabolic clearance, and bioactivity of TSH have demonstrated important biological roles for the TSH oligosaccharides. Although glycoprotein hormones have proved difficult to crystallize [deglycosylation may aid crystallization (4)], probable tertiary structures have been proposed, and use of monoclonal antibodies and other specialized techniques have allowed the function of domains of the subunits to be postulated.
This article has been cited by other articles:
![]() |
P. Kok, F. Roelfsema, M. Frolich, J. van Pelt, A. E. Meinders, and H. Pijl Bromocriptine Reduces Augmented Thyrotropin Secretion in Obese Premenopausal Women J. Clin. Endocrinol. Metab., April 1, 2009; 94(4): 1176 - 1181. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. H. A. Oliveira, E. R. Barbosa, T. Kasamatsu, and J. Abucham Evidence for Thyroid Hormone as a Positive Regulator of Serum Thyrotropin Bioactivity J. Clin. Endocrinol. Metab., August 1, 2007; 92(8): 3108 - 3113. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. K. Kim, S. B. Song, K. I. Kang, M. Rhee, and K. E. Kim Activation of the Thyroid-Stimulating Hormone {beta}-Subunit Gene by LIM Homeodomain Transcription Factor Lhx2 Endocrinology, July 1, 2007; 148(7): 3468 - 3476. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Kok, F. Roelfsema, M. Frolich, A. E. Meinders, and H. Pijl Spontaneous Diurnal Thyrotropin Secretion Is Enhanced in Proportion to Circulating Leptin in Obese Premenopausal Women J. Clin. Endocrinol. Metab., November 1, 2005; 90(11): 6185 - 6191. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. W. Szkudlinski, V. Fremont, C. Ronin, and B. D. Weintraub Thyroid-Stimulating Hormone and Thyroid-Stimulating Hormone Receptor Structure-Function Relationships Physiol Rev, April 1, 2002; 82(2): 473 - 502. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. T. Torres, L. Ramirez, P. H. Simkin, L. E. Braverman, and C. H. Emerson Effect of Various Doses of Recombinant Human Thyrotropin on the Thyroid Radioactive Iodine Uptake and Serum Levels of Thyroid Hormones and Thyroglobulin in Normal Subjects J. Clin. Endocrinol. Metab., April 1, 2001; 86(4): 1660 - 1664. [Abstract] [Full Text] |
||||
![]() |
J. H. A. Oliveira, L. Persani, P. Beck-Peccoz, and J. Abucham Investigating the Paradox of Hypothyroidism and Increased Serum Thyrotropin (TSH) Levels in Sheehan's Syndrome: Characterization of TSH Carbohydrate Content and Bioactivity J. Clin. Endocrinol. Metab., April 1, 2001; 86(4): 1694 - 1699. [Abstract] [Full Text] |
||||
![]() |
L. Persani, E. Ferretti, S. Borgato, G. Faglia, and P. Beck-Peccoz Circulating Thyrotropin Bioactivity in Sporadic Central Hypothyroidism J. Clin. Endocrinol. Metab., October 1, 2000; 85(10): 3631 - 3635. [Abstract] [Full Text] |
||||
![]() |
L. Persani, S. Borgato, R. Romoli, C. Asteria, A. Pizzocaro, and P. Beck-Peccoz Changes in the Degree of Sialylation of Carbohydrate Chains Modify the Biological Properties of Circulating Thyrotropin Isoforms in Various Physiological and Pathological States J. Clin. Endocrinol. Metab., July 1, 1998; 83(7): 2486 - 2492. [Abstract] [Full Text] |
||||
![]() |
Y. Osuga, M. Kudo, A. Kaipia, B. Kobilka, and A. J. W. Hsueh Derivation of Functional Antagonists Using N-Terminal Extracellular Domain of Gonadotropin and Thyrotropin Receptors Mol. Endocrinol., October 1, 1997; 11(11): 1659 - 1668. [Abstract] [Full Text] |
||||
![]() |
M. Grossmann, B. D. Weintraub, and M. W. Szkudlinski Novel Insights into the Molecular Mechanisms of Human Thyrotropin Action: Structural, Physiological, and Therapeutic Implications for the Glycoprotein Hormone Family Endocr. Rev., August 1, 1997; 18(4): 476 - 501. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Glinoer The Regulation of Thyroid Function in Pregnancy: Pathways of Endocrine Adaptation from Physiology to Pathology Endocr. Rev., June 1, 1997; 18(3): 404 - 433. [Abstract] [Full Text] |
||||
![]() |
Y. Bobovnikova, P. N. Graves, H. Vlase, and T. F. Davies Characterization of Soluble, Disulfide Bond-Stabilized, Prokaryotically Expressed Human Thyrotropin Receptor Ectodomain Endocrinology, February 1, 1997; 138(2): 588 - 593. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |